DOUGLAS SAYLOR: Open Payments
NPI 1295505295 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $261 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $140 |
| ABBVIE INC. | 5 | $83 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, SPRAVATO, UBRELVY, REXULTI, Qelbree.
Industry payments across KY — which companies pay providers there.
